SHELLI KESLER to Cross-Sectional Studies
This is a "connection" page, showing publications SHELLI KESLER has written about Cross-Sectional Studies.
Connection Strength
0.492
-
Subjective cancer-related cognitive impairments and salience network connectivity in breast cancer survivors. J Cancer Surviv. 2023 08; 17(4):967-973.
Score: 0.110
-
Cortical Brain Age from Pre-treatment to Post-chemotherapy in Patients with Breast Cancer. Neurotox Res. 2020 Apr; 37(4):788-799.
Score: 0.090
-
Exploring Relationships Among Peripheral Amyloid Beta, Tau, Cytokines, Cognitive Function, and Psychosomatic Symptoms in Breast Cancer Survivors. Biol Res Nurs. 2020 01; 22(1):126-138.
Score: 0.089
-
Identifying cytokine predictors of cognitive functioning in breast cancer survivors up to 10?years post chemotherapy using machine learning. J Neuroimmunol. 2018 07 15; 320:38-47.
Score: 0.080
-
Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun. 2013 Mar; 30 Suppl:S109-16.
Score: 0.053
-
Biomarkers panels can predict fatigue, depression and pain in persons living with HIV: A pilot study. Appl Nurs Res. 2020 04; 52:151224.
Score: 0.022
-
Neurocognitive deficits in older patients with cancer. J Geriatr Oncol. 2018 09; 9(5):482-487.
Score: 0.020
-
Sleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical management. Biol Blood Marrow Transplant. 2014 Oct; 20(10):1465-84.
Score: 0.015
-
The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children. Diabetes Care. 2011 Jul; 34(7):1458-62.
Score: 0.012